Blog
RSS FeedPosted by Michael Wonder on 04 Oct 2016
Costs and concerns in cancer care
5 October 2016 - Some recently developed anticancer drugs appear to be a major advance. ...
Posted by Michael Wonder on 02 Oct 2016
Schedule of Pharmaceutical Benefits - 1 October 2016 update
1 October 2016 - The 1 October 2016 issue of the Schedule of Pharmaceutical Benefits sees a number of new ...
Posted by Michael Wonder on 01 Oct 2016
Breast cancer drug tamoxifen listed on Pharmaceutical Benefits Scheme
1 October 2016 - More Australian women will have access to a preventative breast cancer medicine that has been listed on ...
Posted by Michael Wonder on 30 Sep 2016
Recommendations made by the PBAC - August 2016
30 September 2016 - The outcomes from the August 2016 PBAC meeting are now available. ...
Posted by Michael Wonder on 19 Sep 2016
Real-world evidence: a comparison of the Australian Herceptin Program and clinical trials of trastuzumab for HER2-positive metastatic breast cancer
19 September 2016 - Estimating the real-world cost-effectiveness of a new drug relies on understanding the differences between clinical trial data ...
Posted by Michael Wonder on 31 Aug 2016
Schedule of Pharmaceutical Benefits - 1 September 2016 update
1 September 2016 - The 1 September 2016 issue of the Schedule of Pharmaceutical Benefits sees a number of new ...
Posted by Michael Wonder on 20 Aug 2016
Cancer fight club
21 August 2016 - When Steven Jones-Evans was diagnosed with bladder cancer, the prognosis was grim. His only hope was new ...
Posted by Michael Wonder on 11 Aug 2016
1 September 2016 changes to PBS efficient funding of chemotherapy
11 August 2016 - From 1 September 2016, approved suppliers will need to provide additional information when claiming eligible efficient funding ...
Posted by Michael Wonder on 08 Jul 2016
Rare Cancers Australia lodges PBAC submission
8 July 2016 - Rare Cancers Australia has lodged a submission for the reimbursement of MSD's Zolinza (vorinistat) for cutaneous T-cell ...
Posted by Michael Wonder on 26 Jun 2016
Experimental immunotherapy drug reduces rare tumour size 'dramatically'
24 June 2016 - An experimental immunotherapy drug treatment has significantly reduced the size of a critically ill 36-year-old woman's rare ...
Posted by Michael Wonder on 20 Jun 2016
Valuing the benefits of new anti-cancer drugs
20 June 2016 - Improvements in survival and cancer-related symptoms must be weighed up against treatment-related adverse effects and financial burden. ...
Posted by Michael Wonder on 19 Jun 2016
Cancer patients hurt by lack of informed choice on costs, options
20 June 2016 - Doctors who are not upfront with cancer patients about likely out-of-pocket costs and other options are causing ...
Posted by Michael Wonder on 15 Jun 2016
Why cancer can cost more the rarer it is
15 June 2016 - The Pharmaceutical Benefits Scheme is an integral part of the Australian health system. It theoretically provides affordable ...
Posted by Michael Wonder on 07 Jun 2016
Registration and reimbursement of new cancer medicines in Australia
7 June 2016 - This letter to the Editor of Value in Health Regional Issues for Asia responds to a ...
Posted by Michael Wonder on 13 May 2016
Drug that saved Ron Walker could help wide range of cancer patients
13 May 2016 - A drug that saved Ron Walker from melanoma may also be able to save patients from 30 ...